Get started
Author

Ali Darvishi

Measuring Catastrophic Health Expenditures and its Inequality: Evidence from Iran’s Health Transformation Program
2019 · Vahid Yazdi-Feyzabadi, Mohammad Hossein Mehrolhassani, et al. · Health Policy and Planning · 38
Economic evaluation of a national vitamin D supplementation program among Iranian adolescents for the prevention of adulthood type 2 diabetes mellitus
2022 · Narges Zandieh, Mohsen Rezaei Hemami, et al. · BMC Complementary Medicine and Therapies · 28
PDF
Cost-benefit Analysis of IUI and IVF based on willingness to pay approach; case study: Iran
2020 · Ali Darvishi, Reza Goudarzi, et al. · PLoS ONE · 28
PDF
Sarcopenia screening strategies in older people: a cost effectiveness analysis in Iran
2021 · Ali Darvishi, Mohsen Rezaei Hemami, et al. · BMC Public Health · 25
PDF
Socioeconomic inequalities in type 2 diabetes mellitus: a study based on a population-based survey in Iran
2024 · Ali Darvishi, Adeleh Nikkhah, et al. · BMC Public Health · 16
PDF
Cost-effectiveness analysis of sarcopenia management interventions in Iran
2023 · Ali Darvishi, Gita Shafiee, et al. · BMC Public Health · 14
PDF
Economic burden of Type 2 diabetes in Iran in 2022
2025 · Amin Mohammadi, Mahshad Goharimehr, et al. · BMC Public Health · 13
PDF
Economic burden of sarcopenia-related disability in the elderly population: a study in Iran
2024 · Ali Darvishi, Adeleh Nikkhah, et al. · BMC Research Notes · 8
PDF
Estimation the medical cost of multiple sclerosis in Iran; 2019–2020
2022 · Mina Asadollahi, Ali Darvishi, et al. · BMC Health Services Research · 8
PDF
Public preferences regarding the priority setting criteria of health interventions for budget allocation: results of a survey of Iranian adults
2022 · Ali Darvishi, Rajabali Daroudi, et al. · BMC Public Health · 7
PDF
The cost-effectiveness analysis of a nationwide vitamin D supplementation program among Iranian adolescents for adulthood cardiovascular diseases prevention
2021 · Narges Zandieh, Mohsen Rezaei Hemami, et al. · Public Health · 7
Cost-utility analysis of Pembrolizumab compared to other alternative immunotherapy and chemotherapy treatments for patients with advanced melanoma in Iran
2023 · Negin Bashari, Majid Safaei Lari, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 6
Fairness in household financial contribution to the Iran’s healthcare system from 2008 to 2018
2021 · Ali Darvishi, Mostafa Amini-Rarani, et al. · BMC Research Notes · 5
PDF
Cost-benefit analysis of stroke rehabilitation in Iran
2023 · Ali Darvishi, Mirtaher Mousavi, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 3
Tenecteplase in managing acute ischemic stroke: a long-term cost–utility analysis in Iran
2022 · Kosar Hajian, Ramin Abdi Dezfouli, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 3
Cost-utility analysis of Cryoballoon ablation versus Radiofrequency ablation in the treatment of paroxysmal atrial fibrillation in Iran
2022 · Ali Darvishi, Parham Sadeghipour, et al. · PLoS ONE · 3
PDF
A short-term economic evaluation of early insulin therapy compared to oral anti-diabetic drugs in order to reduce the major adverse events in type 2 diabetes patients in Iran
2024 · Ramin Heshmat, Ali Darvishi, et al. · Current Medical Research and Opinion · 2
Cost-utility analysis of multiple sclerosis rehabilitation in Iran
2023 · Rajabali Daroudi, Mirtaher Mousavi, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2
Is vitamin D supplementation program in Iranian schools effective in reducing adolescent depressive symptoms? Cost effectiveness study
2023 · Seyed Vahid Jasemi, Zhale Zandieh, et al. · BMC Public Health · 2
PDF
Economic Burden of Multiple Sclerosis Drugs in Iran during 2011-2019
2023 · Mina Asadollahi, Ali Darvishi, et al. · Iranian Journal of Public Health · 2
Economic Evaluation of Rehabilitation of Spinal Cord Injury Patients in Iran in 2019
2022 · Mirtaher Mousavi, Rajabali Daroudi, et al. · فصلنامه علمی پژوهشی توانبخشی · 2
PDF
Cost-benefit analysis of pharmaceutical treatments of infertility using willingness to pay approach
2018 · Ali Darvishi, Reza Goudarzi, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 2
Cost effectiveness analysis of six non insulin agents for type 2 diabetes in Iran using a patient level simulation with UKPDS OM2
2025 · Ali Darvishi, Rajabali Daroudi, et al. · Scientific Reports · 1
PDF
The cost-utility analysis of adding ocrelizumab to the treatment plan for primary progressive multiple sclerosis in Iran
2024 · Ali Darvishi, Ramin Abdi Dezfouli, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 1
Serum Concentrations of Thyroid-Stimulating Hormone, Triiodothyronine, and Thyroxine in Outpatients Infected with SARS-CoV2 in Khuzestan Province, Iran: A Disease Clinical Course Approach
2022 · Mahshid Naghashpour, Ali Darvishi, et al. · Medicina · 1
PDF
Works count: 59
Citation count: 232
H-index: 8
I10-index: 7
Year
Topic
Type